The novel 6-0-methyl tricyclic ketolides TE-802and its analogs were synthesized by two successive cyclization reactions, 1 1 , 12-cyclic carbamate formation by intramolecular Michael addition and 9, 1 1 -diazaheptene ring construction by intramolecular dehydration reaction. These new tricyclic ketolides exhibited good in vitro antibacterial activity against not only erythrornycin-susceptible strains but also erythromycin-resistant Staphylococcus aureus and Streptococcus pneumoniae, which are problematic pathogens of nosocomial and communityacquired respiratory tract infections, respectively.
new tricyclic ketolides exhibited good in vitro antibacterial activity against not only erythrornycin-susceptible strains but also erythromycin-resistant Staphylococcus aureus and Streptococcus pneumoniae, which are problematic pathogens of nosocomial and communityacquired respiratory tract infections, respectively. A number of EM-A derivatives have been prepared in order to improve the poor bioavailability of EM-A, which results from its acid-instability1}. These efforts contributed to successful development of so-called the second-generation macrolide antibiotics such as clarithromycin (CAM, 2)2\ roxithromycin and azithromycin (AZM, 3) 3) in the early 1990s. These macrolide antibiotics have increased acid stability and exhibit some pharmacological profiles superior to those of EM-A. Recently, however, the increase in frequency of erythromycin-resistant bacteria has become a serious therapeutic problem4). Thus, new macrolides having expanded antibacterial spectra including erythromycinresistant organisms have been expected. In the course of our study on chemical modification of EM-A, we found a unique synthetic method for the construction of a 9,ll; 1 1,12-cyclic system. Herein, we report the synthesis and evaluation of novel ketolides with a unique tricyclic 
Chemi stry
It has been reported5) that 10,ll-anhydro-12-(9-acyl imidazolide could be converted into 1 1 , 12-cyclic carbamate by treatment with various amines. On the other hand, the derivation of 9-keto moiety to an imino group has also been known as 9-hydrazine6) and 9-oxime7) derivatives. Wehave applied these independent findings to a design of a new macrolide antibiotic with a unique tricyclic aglycone nucleus. Our synthetic strategy is shown in Figure 2 . We planned to treat 12-O-acyl imidazolide with alkyldiamine to form ll,12-cyclic carbamate followed by cyclization between 9-keto with the remaining amino group on the alkyl side chain on the ll,12-carbamate 'ring by intramolecular dehydration reaction. According to our plan, compound 5 was treated with 10 equivalents of ethylenediamine in acetonitrile (CH3CN)at ambient temperature. With disappearance of starting material 5, ll,12-cyclic carbamate compound 6a newly appeared. After deprotection of the acetyl group at the 2'-position of 6a, the structure of 7a was determined by NMR spectroscopic analysis. In the *H NMRspectrum of 7a, the olefln proton at the 1 1-position (6.66 ppm) of5 disappeared and a new methine proton (3.66ppm) of 7a was observed.
In the 13C NMRspectrum of7a, C-l1 (137.8ppm) in 5 was shifted up field to 60.2ppm in 7a. In addition, in the 1H-Detected Multiple-bond Heteronuclear Multiple Quantum Coherence (HMBC) spectrum of 7a, correlation between 1 1-H and the carbonyl carbon of carbamate was observed. These spectral data indicated formation of the desired 5-memberedcarbamate ring. Interestingly, we predominantly obtained compound 6a, which had natural 10-R stereochemistry. Wewill discuss the stereochemistry at the 10-position in detail later. Next, we investigated the intramolecular dehydration reaction of 7a~c to obtain a 9,1 1-ring. This diazaheptene ring construction process was the key step in obtaining the tricyclic compound. In our initial investigations, the free amine 7a was heated in alcohol (EtOH or MeOH)for a few hours to obtain a 9-imino compound. However, we detected only a trace amount of the desired 9-imino derivative on TLCanalysis.
Wetherefore investigated reaction conditions for ring construction at the 9-position. It became apparent that the addition of a small excess of organic acids (1.5-2.5 equiv) such as formic acid and acetic acid was effective for this reaction. Compound 7a was heated at 60°C with glacial acetic acid (1.9equiv) in EtOH for 4hours to obtain the corresponding 9-imino compound 9a in good yield. In further study, it was revealed that toluene was also a good solvent for intramoleculer dehydration reaction. In the 13C
NMRspectrum of 9a, the 9-keto signal disappeared (216.1 ppm in 7a) and the 9-imine signal was newly observed at 181.5ppm. Formation of a diazaheptene ring was confirmed by 2D NMR studies (^H COSY,^-^C COSY and HMBC) of 9a. As typical evidence, correlation between the proton of 1 1-NCH2-and each carbon of C-l 1 and carbonyl of carbamate, and between the proton of 9=NCH2-and carbon of C-9 have been observed in HMBC spectrum of 9a. Then compound9a was treated with 5 equiv of l ,8-diazabicyclo [5, 4, 0] undec-7-ene (DBU) in MeOHto obtain compound10a. Since we could obtain the desired tricyclic macrolide, we attempted to synthesize 9,1 1-diazaoctene and diazanonene ring compounds. For the above purpose, 1 1-Af-aminopropyl and 1 1-7V-aminobutyl ll,12-cyclic carbamates, synthesized from 5 using 1,3-diaminopropane and 1,4-diaminobutane according to the synthesis of 6a, were subjected to the above ring construction conditions, but we could not obtain the expected diazaoctene and diazanonene derivatives. Perhaps, the aminoethyl group would be a favorable chain length for intramolecular ring construction at 9-position, while the Scheme 1. aminopropyl and aminobutyl groups may be difficult to approach to the carbonyl group at 9-position due to its long chain length. Onthe other hand, we found 3-keto derivatives exhibiting good in -vitro® and in vivo antibacterial activities in our previous studies of modification at the 3-position of erythromycins. Wetherefore determined the conversion of tricyclic macrolides to 3-keto derivatives. Then 9a was treated with 2 n hydrochloric acid to obtain decladinosyl compound lla in high yield. Compound lid was also synthesized from 6d in a manner similar to that of lla (Scheme 2). In this step, we confirmed that removal of cladinose could be carried out prior to 9, 1 1-cyclization. We have synthesized compoundslib and lie from compounds 7b and 7c, derived from 5 with 1,2-diaminopropane, by the latter method. Compound8b and its epimer 8c were separated in this step using silica gel column chromatography. After protection of the 2'-hydroxy group of tricyclic compounds lla~d by acetic anhydride, obtained 12a~d
were subjected to modified Pfltzner-Moffat oxidation9) (1-(3 -dimethylaminopropyl have therefore studied the stereochemistry at the diazaheptene ring by NOESYexperiment. The NOESY spectrum of 16b revealed NOEenhancement between the methine proton on 9, l l -A^-(2-methyl)nitriloethano moiety and the proton of 10-CH3. On the other hand, the NOESY spectrum of 16c revealed NOEenhancements between the methine proton on 9, l l-A^-(2-methyl)nitriloethano moiety and each proton of 6-OCH3 and ll-H. These results revealed that the stereochemistry of 9,l l-A^(2-methyl)-nitriloethano moiety to be^-configuration for 16b and Sconfiguration for 16c. The stereochemistry and molecular structure of 16c were determined by X-ray crystallographic analysis.
9-Amino compound 17 was synthesized from 16a using NaBH3CNand acetic acid in methanol. In the 13C NMR spectrum of 17, up field shift of C-9 (70.5 ppm (doublet) in 17) from 181.0ppm (singlet) in 16a was observed. The stereochemistry of the 9-position of 17 was determined by NOESY experiment. The NOESY spectrum of 17 revealed NOEenhancements between the proton of 9-H and each proton of 8-CH3 and 10-CH3. Thus, the stereochemistry of C-9 in 17 was determined as 5-configuration. In Vitro Antibacterial Activity
In vitro activities (MICs) were measured using standard agar dilution methods. First, we studied structure-activity relationships for a variety of 3-positions of tricyclic macrolides (Table 3) . Compound 10a, a tricyclic compound, was 2 to 4times more active than CAM (2) against erythromycin-susceptible organisms, whereas 10a was inactive against erythromycin-resistant organisms, similar to CAM (2) . Compound lla, decladinosyl 10a, exhibited weak in vitro activity against most organisms (MICs : 3.13~>100/xg/ml). Compared with 10a and lla, TE-802 (16a), a 3-keto compound, exhibited excellent activity against erythromycin-susceptible and -resistant strains, except for highly resistant S. pneumoniae 221.
Although it had been thought that the cladinose at the 3-position was essential for antibacterial activity, antibacterial activity could be revived by oxidation of the 3-hydroxy group. The above results revealed that a combination of tricyclic aglycon and 3-keto structure yielded strong antibacterial activity. Next, in vitro activities of tricyclic ketolides 16a~d and 17 were compared with those of CAM (2) and AZM (3) against both standard strains and erythromycin-resistant organisms (Tables 4 and 5 ). As shown in Table 4 , the potency of 9-amino compound 17 was equal to that of AZM(3), and 2 or 4times less active than those of CAM (2) and 9-imino compounds 16a~d. The potencies of 16a~d were similar to that of CAM (2) against most standard strains, but 4 to 32times stronger than that of CAM (2) against Enterococci.
In addition, tricyclic ketolides exhibited greatly improved All spectra were taken in CDC13at 500 MHzand chemical shifts are reported in ppm relative to TMS. Inoculumn size : 106 cfu/ml. (attack B). In our case, the desired 5-membered cyclic carbamate could be predominantly obtained. Wespeculate that the carbamate nitrogen atom would be spatially close to the end carbon (1 1-C) of enone in the Michael addition for attack on A. Furthermore, the 5-membered product would be more stable than the 8-menbered product thermodynami c al ly. It has been reported10) by Griesgraber et ah that the reaction of 3-keto derivative of 5 with hydrazine yielded the kinetically unnatural 10-$ 1 1,12-cyclic carbazate, and that the stereochemistry at the 10-position could be thermodynamically converted to natural IQ-R. In our case, we obtained compound 6a with natural 10-R stereochemistry with high selectivity (10R : 10S=92 : 8) with use of a large excess of ethylenediamine (lOequiv) even at room temperature. We speculate that the basicity of excess ethylenediamine is preferable for obtaining the natural 1 0-R configuration.
The ratio of 10R/10S became 80/20 when 4.0 equiv of ethylenediamine was used, and the ratio of 10R/ 10S ultimately reversed to 40/60 with use of 2.5 equiv of diamine.
As a new ketolide series, ABT-773 H) and telithromycin12) have been reported by Abbott Laboratories and Aventis Pharma. These compounds were also effective against erythromycin-resistant organisms similar to TE-802. The structural feature of these compoundsis their possession of one or two aromatic heterocycles on a side chain at 6-(in ABT-773) or 1 1-(in telithromycin) position.
It appears that these aromatic heterocycles play a significant role in binding to ribosomes of erythromycinresistant bacteria13). Among recent ketolides, TE-802 is conspicuously unique in having the heterocycle introduced not on a side chain but inlaid into the aglycon moiety itself as a diazaheptene ring. Mass Spectrometry (ESI-MS). HRFAB-MSwas recorded on a JMS-SX102(JEOL) mass spectrometer.
\4"-Di-O-acetyl-6-O-methylerymromycin A (4)
To a stirred solution of 2 (500g, 0.668mol) and 4-dimethylaminopyridine (32.7 g, 0.267 mol, 0.4 equiv) in CH2C12 (1000 ml) was added acetic anhydride (221 ml, 2.34 mol, 3.5 equiv) in one portion, and the mixture was stirred for 2 days at ambient temperature. 170.4 (4"-OCOCH3), 175.5 (C-l), 221.1 (C-9).
To a solution of 4 (150g, 0.180mol) and 1,1'-carbonyldiimidazole (73.1 g, 0.451 mol, 2.5 equiv) in DMF -THF (2 : 3, 600ml) was added 60% sodium hydride (9.37 g, 0.234mol, 1.3 equiv) with ice-cooling. After the reaction mixture was stirred for 3.5 hours at ambient temperature, H2O(1000ml) was added at 0°C. The above mixture was extracted with EtOAcand the organic layer was washed with H2O and brine, dried over MgSO4and evaporated under reduced pressure. To a stirred solution of 7a (5.00g, 5.91 mmol) in EtOH (60ml) was added glacial acetic acid (0.630 ml, 1 1.0 mmol, 1.9 equiv). The reaction mixture was stirred at 60°C for 4 hours and stirred overnight at room temperature. The reaction mixture was concentrated under reduced pressure followed by the addition of CHC13and 2 n NaOHsoln. The two layers were separated and the organic layer was washed with H2O and brine, dried over MgSO4and evaporated under reduced pressure. Silica gel column chromatography (CHCl3-MeOH-NH4OH(30 : 1 : 0.1)) of the crude product yielded 9a (3.20 g, 65%) as a white powder. Crystallization of 9a from diisopropyl ether afforded colorless needles, mp 170.5 (4^OCOCH3), 176.6 (C-l), 181.5 (C-9).
1 l -Amino-9-deoxo-l l -deoxy-9, H -A^-nitriloethano-6-Omethylerythromycin A 1 1 , 12-Cyclic Carbamate (10a)
The solution of9a (7.00g, 8.34mmol) and DBU (6.2ml, 41.5mmol, 5.0equiv) in MeOH(70ml) was refluxed for 4 hours and then concentrated under reduced pressure. The residue was dissolved in CHC13and the organic layer was (C-l' ), 156.4 (carbamate), 175.6 (C-l), 181.7 (C-9).
2/-O-Acetyl-l l-amino-9-deoxo-l l-deoxy-9,l l-A^-nitriloethano-5 -O-desosaminyl-6-(9-methylerythronolide A 1 1, A solution of lla (2.00g, 3.13mmol) in acetone (20ml) was treated with acetic anhydride (0.540ml, 5.71 mmol, 1.8 equiv) at room temperature for 3 hours. The reaction was quenched by addition of 0.2N NaOHsoln and extracted 1 l -Amino-9-deoxo-3, l l -dideoxy-9, 1 1 -iV-nitriloethano-
The solution of 14a (1.71g, 2.51mmol), DMSO (3.56 ml, 50.2 mmol, 20.0 equiv), l-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (2.88 g, 15.0mmol, 6 .0 equiv) in CH2C12 (17 ml) and pyridine hydrochloride (2.90 g, 15.0mmol, 6.0equiv ) was stirred at room temperature for 3.5 hours. The reaction mixture was concentrated under reduced pressure followed by the addition of chloroform (CHC13) and 2n NaOHsoln. The two layers were separated and the organic layer was washed with H2Oand brine, dried over MgSO4and evaporated under reduced pressure to give crude 15a (1.53 g). The crude 15a (1.53 g) was dissolved in MeOH(15 ml) and stirred at room temperature overnight. Carbamate (8b and 8c)
The mixture of 7b and 7c (280g, 0.373jnol) was dissolved in 2n HC1 (900ml) and stirred at 60°C for 3 hours. To the reaction mixture was added 2N NaOHsoln (1200ml), and the resulting precipitates were filtered, washed with H2Oand dried to afford a mixture of 8b and 8c (144 g). The above filtrate (aqueous layer) was extracted with EtOAc, and the organic layer was washed with brine, dried over MgSO4 and concentrated under reduced pressure. The residue was crystallized from diethyl ether to yield a mixture of 8b and 8c (28.2g). The combined mixture of 8b and 8c (172g) was charged to silica gel column chromatography (CHC13 -MeOH-NH4OH (15 : 1 : 0.1)) for separation of single isomer 8b (58.2g, 24% from 5) and another isomer 8c (65.8 g, 28% from 5 (C-l' ), 157.4 (ll-NCOO-), 175.6 (C-l), 215.4 (C-9).
1 l-Amino-9-deoxo-l l-deoxy-9,1 1-A^-(27?-methyl)- 1 l -Amino-9-deoxo-3, l l -dideoxy-9, 1 l -A^-(2^-methyl)-nitriloethano-3 -oxo-5-O-desosaminyl-6-O-methylerythronolide A 1 1, This compound was prepared from lib (60.0g, 91.8 mmol) in a manner similar to that described for the preparation of 16a (2'-0-acetylation, oxidation of 3-OH and 2'-deacetylation).
Obtained with 2n HC1 soln (200ml) in a manner similar to that described for the preparation of lla to obtain crude 13d.
Then crude 13d was treated with MeOH to remove the acetyl group at 2'-position followed by crystallization from 1 l -Amino-9-deoxo-3, l l -dideoxy-9, 1 l -A^-(2,2-dimethyl)-nitriloethano-3 -oxo-5 -O-desosaminyl-6-O-methylerythronolide A 1 1, This compound was prepared from lid (52.7g 78.9 mmol) in a manner similar to that described for the preparation of 16a (2'-0-acetylation, oxidation and 2'-deacetylation).
Obtained crude product was crystallized from CH3CN to yield 16d (29.5g, 56%) Streptococcus pneumoniae 229 and 221 are MLSB-resistant strains encoded by ermB gene. Streptococcus pneumoniae 225 carries both mefA and ermB genes.
